Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma

NCT00924001 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

1

Enrollment

NIH

Sponsor class

Stopped study was stopped due to low accrual

Conditions

Melanoma
Malignant Melanoma
Melanoma, Experimental

Interventions

DRUG: DMF5 Melanoma Reactive TIL
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Aldesleukin

Sponsor

National Cancer Institute (NCI)